Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00573716 · ClinicalTrials.gov registry record
Comparison of Bone Mineral Density Changes During Tx With Risperidone or Aripiprazole in Adolescents
A clinical trial, sponsored by Creighton University.
- Completed
- Registry status
- 60
- Enrollment target
NCT00573716: Completed study, sponsored by Creighton University.
NCT00573716 is a clinical trial that has completed, run by Creighton University. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00573716 has completed, sponsored by Creighton University.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
This study examines if the use of antipsychotic medications might contribute to an interruption in bone mineral development and/or a reduction in bone mineral content in adolescents.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2006-10 |
| Est. Completion | 2009-10 |
What the finished NCT00573716 record still lists
NCT00573716 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00573716 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00573716 about?
NCT00573716 is a clinical study titled "Comparison of Bone Mineral Density Changes During Tx With Risperidone or Aripiprazole in Adolescents". This study examines if the use of antipsychotic medications might contribute to an interruption in bone mineral development and/or a reduction in bone mineral content in adolescents.
What is the current status of trial NCT00573716?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2006-10. Estimated completion is 2009-10.
Who is sponsoring clinical trial NCT00573716?
This trial is sponsored by Creighton University, which has 98 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia